Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • CDK
    (5)
  • Apoptosis
    (2)
  • Autophagy
    (1)
  • Chk
    (1)
  • ERK
    (1)
  • FLT
    (1)
  • GSK-3
    (1)
  • PDGFR
    (1)
  • Src
    (1)
Filter
Search Result
Results for "

cdc2/cyclinb

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    6
    TargetMol | Inhibitors_Agonists
  • Natural Products
    1
    TargetMol | Natural_Products
Olomoucine
T21588101622-51-9In house
Olomoucine is an ATP-competitive inhibitor of Cdk2 cyclin A, Cdc2 CyclinB, CDK2 CyclinE, CDK5 p35, and ERK1 p44 MAP kinase with IC50s of 7, 7, 7, 3, and 25 µM, respectively. It regulates the cell cycle and exhibits anti-melanin tumor activities.
  • Inquiry Price
Size
QTY
Seliciclib
R-roscovitine, Roscovitine, CYC202
T2095186692-46-6
Seliciclib (Roscovitine) is a potent inhibitor of Cdk2 cyclin E (IC50=0.1 µM). Seliciclib also inhibits Cdk7 cyclin H, Cdk5 p35 and Cdc2 cyclin B (IC50=0.49 0.16 0.65 µM). Seliciclib has antitumor activity.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
Purvalanol A
NG-60
T2059212844-53-6
Purvalanol A (NG-60) is an effective and cell-permeable CDK inhibitor with IC50 of 70 4 35 850 nM for cdk2-cyclin A B E, and cdk4-cyclin D1, respectively.
  • Inquiry Price
Size
QTY
ng 52
NG-52, NG52, Compound 52
T2028212779-48-1
NG 52 (NG-52) is a cell-permeable, reversible, and ATP-compatible inhibitor of the cell cycle-regulating kinase Cdc28p and the related Pho85p kinase.
  • Inquiry Price
Size
QTY
Butyrolactone I
Olomoucin
T2519287414-49-1
Butyrolactone I (Olomoucin) is an ATP-competitive inhibitor of CDK and cdc2 kinase family. Butyrolactone I shows antitumor effects in non-small cell lung, small cell lung, and prostate cancer cell lines.
  • Inquiry Price
6-8 weeks
Size
QTY
TargetMol | Citations Cited
CHIR-124
CHIR124, CHIR 124
T6350405168-58-3
CHIR-124 is an effective Chk1 inhibitor (IC50: 0.3 nM). It has 2, 000-fold selectivity against Chk2, 500- to 5, 000-fold less activity against Cdc2 and CDK2 4.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale